Pomerantz Law Firm Files Class Action Lawsuit Against Dow Inc. and Executives
On September 3, 2025, Pomerantz LLP announced the initiation of a class action lawsuit against Dow Inc. (NYSE: DOW) and its senior executives. Emphasizing the gravity of the situation, the lawsuit has been formally lodged in the United States District Court for the Eastern District of Michigan under docket number 25-cv-12744. This legal action seeks to claim damages for all individuals and entities, except the defendants, who purchased or otherwise acquired Dow securities between January 30, 2025, and July 23, 2025, a period now referred to as the 'Class Period'. The core issue is centered around alleged breaches of federal securities laws as set forth in Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 which emanate from misleading statements and omissions regarding Dow's financial health and business operations. Investors who fall within the defined class have until October 28, 2025, to request the court appoint them as the Lead Plaintiff.
The legal representation, Pomerantz LLP, is recognized for its expertise in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, the firm has a storied history in securities class action law, recovering billions for victims of corporate misconduct. Dow Inc., an eminent player in materials science, directly engages in key industries such as packaging, consumer applications, and infrastructure, showcasing its diversified operations across six global business units.
Notably, Dow has traditionally emphasized its robust dividend policy as a significant selling point for investors. CEO Jim Fitterling has repeatedly noted the critical nature of dividends to the company’s investment proposition, with a large percentage of shareholders relying on regular payouts. However, amid ongoing challenges in the materials science sector, coupled with economic uncertainties linked to tariffs, Dow's leadership consistently assured stakeholders that the company was strategically positioned to withstand these headwinds and uphold its dividend commitments.
Despite this confidence, the landscape changed dramatically during the class period, as evidence began to surface indicating that Dow was, in fact, struggling more than publicly communicated. The complaint alleges that defendants failed to adequately disclose the vulnerabilities facing the company, particularly regarding competitive pressures, demand fluctuation, and the rates of product oversupply in global markets.
This discord between public statements and actual conditions came to a head on June 23, 2025, when BMO Capital issued a downgrade of Dow’s stock from 'Market Perform' to 'Underperform' following revelations of continued market weakness and challenges in maintaining its dividend. As a result, Dow’s shares suffered a considerable dip, indicating market distress and investor concern.
On July 24, 2025, Dow's financial disclosures painted a bleak picture, revealing a significant per-share loss much larger than anticipated, alongside a decline in net sales year-over-year, prompting further stock depreciation. The announcement that Dow would be halving its dividend set off alarm bells among shareholders, resulting in an immediate and steep decline in stock value, as investor confidence plummeted.
The ramifications of these developments have been profound, drawing the scrutiny of regulators and the investor community alike. Pomerantz LLP continues its pursuit of justice for affected parties, driven by a commitment to uphold the rights and interests of investors who have faced losses due to corporate malfeasance. If you believe you're part of this impacted group, further information can be acquired by contacting Pomerantz directly, or by accessing detailed documentation available through their official website. This ongoing legal saga illustrates the pivotal role firms like Pomerantz play in navigating the intricate terrain of securities law and the relentless quest for investor reclamation in the face of corporate shortcomings.
The legal representation, Pomerantz LLP, is recognized for its expertise in corporate, securities, and antitrust class litigation. Founded by Abraham L. Pomerantz, the firm has a storied history in securities class action law, recovering billions for victims of corporate misconduct. Dow Inc., an eminent player in materials science, directly engages in key industries such as packaging, consumer applications, and infrastructure, showcasing its diversified operations across six global business units.
Notably, Dow has traditionally emphasized its robust dividend policy as a significant selling point for investors. CEO Jim Fitterling has repeatedly noted the critical nature of dividends to the company’s investment proposition, with a large percentage of shareholders relying on regular payouts. However, amid ongoing challenges in the materials science sector, coupled with economic uncertainties linked to tariffs, Dow's leadership consistently assured stakeholders that the company was strategically positioned to withstand these headwinds and uphold its dividend commitments.
Despite this confidence, the landscape changed dramatically during the class period, as evidence began to surface indicating that Dow was, in fact, struggling more than publicly communicated. The complaint alleges that defendants failed to adequately disclose the vulnerabilities facing the company, particularly regarding competitive pressures, demand fluctuation, and the rates of product oversupply in global markets.
This discord between public statements and actual conditions came to a head on June 23, 2025, when BMO Capital issued a downgrade of Dow’s stock from 'Market Perform' to 'Underperform' following revelations of continued market weakness and challenges in maintaining its dividend. As a result, Dow’s shares suffered a considerable dip, indicating market distress and investor concern.
On July 24, 2025, Dow's financial disclosures painted a bleak picture, revealing a significant per-share loss much larger than anticipated, alongside a decline in net sales year-over-year, prompting further stock depreciation. The announcement that Dow would be halving its dividend set off alarm bells among shareholders, resulting in an immediate and steep decline in stock value, as investor confidence plummeted.
The ramifications of these developments have been profound, drawing the scrutiny of regulators and the investor community alike. Pomerantz LLP continues its pursuit of justice for affected parties, driven by a commitment to uphold the rights and interests of investors who have faced losses due to corporate malfeasance. If you believe you're part of this impacted group, further information can be acquired by contacting Pomerantz directly, or by accessing detailed documentation available through their official website. This ongoing legal saga illustrates the pivotal role firms like Pomerantz play in navigating the intricate terrain of securities law and the relentless quest for investor reclamation in the face of corporate shortcomings.
Topics General Business）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.